TELA Bio (TELA)

• Market cap: $78.8M
• 1 day: 8.74%
• 5 days: 16.37%
• 1 month: 4.74%
• 3 months: 34.46%
• 6 months: -23.46%
• Year to date: -30.90%
• 1 year: -33.67%
• 5 years: -85.31%
• 10 years: -85.09%
• Sector: Healthcare
• Industry: Medical Devices

About: TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Employees: 209

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

52% more capital invested

Capital invested by funds: $30M [Q1] → $45.5M (+$15.5M) [Q2]

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

2.86% less ownership

Funds ownership: 62.17% [Q1] → 59.32% (-2.86%) [Q2]

12% less funds holding

Funds holding: 50 [Q1] → 44 (-6) [Q2]

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13